We are live on ! Find out more
AEMD icon

Aethlon Medical

23 hedge funds and large institutions have $355K invested in Aethlon Medical in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.95% less ownership

Funds ownership: 8.61%5.66% (-2.9%)

4% less funds holding

Funds holding: 2423 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

69% less capital invested

Capital invested by funds: $1.15M → $355K (-$790K)

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
3
Reduced
4
Closed
9
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
-$69K

AEMD Hedge Fund Activity: Q4 2022 in Review

23 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2022, worth a combined $355K — down 69% from $1.15M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AEMD and 8 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was Jane Street, adding an estimated $56.5K. The largest seller was Vanguard Group, cutting an estimated $386K.

  • 23 institutional investors held Aethlon Medical (AEMD) as of Q4 2022, down from 24 in Q3 2022.
  • Funds reported $355K of Aethlon Medical stock for Q4 2022, down 69% quarter-over-quarter.
  • 8 funds opened new Aethlon Medical positions in Q4 2022 and 9 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q4 2022 was Jane Street, an estimated $56.5K added.
  • The largest Aethlon Medical seller in Q4 2022 was Vanguard Group, an estimated $386K sold.

Based on aggregated 13F filings for Q4 2022.